Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Fuji
Argus Health
AstraZeneca
Moodys
Healthtrust
Boehringer Ingelheim
McKesson
Cipla

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:High affinity RNA ligands of basic fibroblast growth factor
Abstract: Methods are described for the identification and preparation of nucleic acid ligand solutions to basic fibroblast growth factor (bFGF). Included in the invention are nucleic acid ligands to bFGF which are inhibitors of bFGF and 2'-amino-modified RNA ligands to bFGF.
Inventor(s): Janjic; Nebojsa (Boulder, CO), Gold; Larry (Boulder, CO)
Assignee: Gilead Sciences, Inc. (Forster City, CA)
Filing Date:Jul 06, 2004
Application Number:10/885,403
Claims:1. A pharmaceutical composition comprising a non-naturally occurring nucleic acid ligand to basic fibroblast growth factor (bFGF), wherein said nucleic acid ligand inhibits the binding of bFGF to its receptor on the surface of a cell.

2. The composition of claim 1 wherein said nucleic acid ligand is single-stranded.

3. The composition of claim 2 wherein said nucleic acid ligand is an RNA ligand.

4. The composition of claim 3 wherein said nucleic acid ligand is comprised of 2'NH.sub.2(2'-amino)modified nucleotides.

5. A method of inhibiting the binding of basic fibroblast growth factor (bFGF) to its receptor on the surface of a cell in vivo comprising administering to said cell the pharmaceutical composition of claim 1.

6. The method of claim 5 wherein said nucleic acid ligand is single-stranded.

7. The method of claim 6 wherein said nucleic acid ligand is an RNA ligand.

8. The method of claim 7 wherein said nucleic acid ligand is comprised of 2'NH.sub.2(2'-amino)modified nucleotides.

9. The method of claim 8 wherein said nucleic acid ligand comprises SEQ ID NO:104.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Covington
Cipla
QuintilesIMS
Express Scripts
Baxter
Boehringer Ingelheim
Chinese Patent Office
Teva
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot